Cleave Biosciences Lands $10,000,000 Series A Financing Round
866 Malcolm Burlingame, CA 94010
The big idea at Cleave is to develop small-molecule chemical compounds that will interact with certain protein pathways that get thrown out of whack in patients with cancer.
Cleave will use the funds to move its lead program into clinical trials and advance its second discovery program.
New Enterprise Associates
Trending on Xconomy
[toplytics period="week" numberposts="3"]